QPS Celebrates 30th Anniversary
Exhibitor: QPS HOLDINGS, LLC
Date: 2026-05-11
Booth No.: M1213
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in 2025. Founded by Dr. Benjamin Chien in 1995 to provide high-quality bioanalytical liquid chromatography with tandem mass spectrometry (LC-MS/MS) contract services, QPS is now recognized as a global leader in contract research. Over the past 30 years, the company has grown from a single office in Delaware, USA to a widely respected, global, full-service CRO with 8 locations spread across the US, EU, Asia, India and Australia, a clinical trial network of over 700 sites and an increased focus on leveraging the power of AI to accelerate clinical trials.
Over the years, QPS has grown from a small molecule bioanalysis shop of three people to a global CRO with more than 1,200 employees. “30 years is a major milestone for QPS and I couldn’t be more proud of the hard-working and innovative people who choose to work at QPS. They are the backbone of the company, and I am very grateful for their valuable contributions,” said founder and CEO of QPS, Dr. Benjamin Chien.
“Through QPS, the pharmaceutical and biotechnology industries have access to dedicated, focused scientific expertise across the drug development spectrum. In facilities around the world, QPS has assembled best-in-class instruments, platforms, people and processes required to conduct the studies necessary to support client drug discovery and development programs focused on obesity, type 2 diabetes, oncology, CNS diseases, cell and gene therapy, and more” said Dr. Chien.
Since its humble beginnings, QPS has expanded its service options, to include pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs, cell therapy products, clinical trials, central lab services, and a full range of clinical research services.
QPS is known for high-quality data, technical expertise, delivery of promised study timelines, collaborative solutions, and customer-focused strategies. Going forward, QPS plans to continue delivering custom-built research services that accelerate pharmaceutical breakthroughs across the globe.
ABOUT QPS HOLDINGS, LLC
QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and Australia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs and cell therapy products, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, and turnkey laboratories and facilities. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers. For more information, visit www.qps.com or email info@qps.com.
More Exhibitor's Press Release
- With over 30 years of experience in automation equipment RADEN AUTOMATIC LTD. / 2026-05-12
- Common Instruments for Nucleic Acid Concentration Detection MEDCLUB SCIENTIFIC CO., LTD. / 2026-05-12
- Feyond-MF200 Multi-Mode Microplate Reader Launched! MEDCLUB SCIENTIFIC CO., LTD. / 2026-05-12
- Multiplex qPCR vs. Singleplex qPCR: Key Differences, Benefits, and Experimental Considerations MEDCLUB SCIENTIFIC CO., LTD. / 2026-05-12
- QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, W QPS HOLDINGS, LLC / 2026-05-11
- QPS Selects Oracle Argus Safety Database QPS HOLDINGS, LLC / 2026-05-11
- Bio-Techne Expands COMET™ Spatial Biology Portfolio with New SPYRE™ Solutions HONG JING CO., LTD. / 2026-05-11
- Bio-Techne Launches Cultrex™ Synthetic Hydrogel to Enhance Reproducibility in 3D Organoid Culture HONG JING CO., LTD. / 2026-05-11
- Aiming for a Guinness World Record! The 3rd International Traditional & Natural Medicine Congress to MEDITHEK ENTERPRISES LTD. / 2026-05-11
- Pharmaceutical Company Donates 3,000 ““AHCHOO” Herbal Sprays to Support Vulnerable Communities Durin MEDITHEK ENTERPRISES LTD. / 2026-05-11
- Rotary International Donates “AHCHOO” Herbal Spray to Tri-Service General Hospital, Supporting Front MEDITHEK ENTERPRISES LTD. / 2026-05-11
- Consumer-Friendly Jelly Formats Redefine Health Supplements with Both Functionality and Enjoyment JOWIN BIOPHARMA, INC. / 2026-05-07
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-05
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-05
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-05
- Youlin Pharmaceutical Debuts at BIO Asia-Taiwan 2026 — Accelerating New Drug Clinical Development wi SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-04-29
- BioLegend Introduces Cell-Vive™ GMP Solutions to Streamline and Scale Cell Therapy Manufacturing BIOLEGEND TAIWAN INC. / 2026-04-28
- Revolutionizing Production Efficiency! Singhania Tableting Unveils One-Stop Smart Tableting Solution ATTRA GIAND INDUSTRIAL CO., LTD. / 2026-04-24
- KMU to Showcase 50+ Cutting-Edge Medical Innovations at BIO Asia–Taiwan 2026 KAOHSIUNG MEDICAL UNIVERSITY / 2026-04-22
- Thermo Fisher Genesys UV Visible Spectrophotometer CHIEFDOM-TEK CO., LTD. / 2026-04-22